Biotech - Press Releases

Date	Title	Company
03-Dec-2019	RORZE Lifescience Partners with Biosero to Commercialize Green Button Go Automation Scheduling Software in Japan, China	Biosero, Inc.
03-Dec-2019	Owkin teams up with NVIDIA and King's College London to deliver AI to hospitals while protecting patient data with Federated Learning	Owkin
03-Dec-2019	VolitionRx Limited Announces Proof of Concept Data in Lymphoma and Leukemia	VolitionRx Ltd
03-Dec-2019	DelMar Pharmaceuticals to Present at the LD Micro 12th Annual Main Event on December 10, 2019	DelMar Pharmaceuticals, Inc.
03-Dec-2019	GEn1E Lifesciences, a Y Combinator-Backed Company, Granted Exclusive License for University of Maryland, Baltimore Drug Portfolio Compound	GEn1E Lifesciences Inc.; UM Ventures
03-Dec-2019	Tangerine Medical adopts MPEG-G data format for end-to-end genomic data processing	GenomSys
03-Dec-2019	Cancer – New Inhibitor Effective Where Others Fail	Karl Landsteiner University of Health Sciences
03-Dec-2019	Announces Distribution Agreement with Apex	Ascension Healthcare plc
03-Dec-2019	ASLAN PHARMACEUTICALS ANNOUNCES PRICING OF $12.8 MILLION PUBLIC OFFERING OF AMERICAN DEPOSITARY SHARES	ASLAN Pharmaceuticals
03-Dec-2019	Hypha Discovery announces “One-Stop Metabolite Shop” solution to support pharmaceutical and agrochemical R&D	Hypha Discovery Ltd
03-Dec-2019	Novasep Launches oXYgene™, a Fully Integrated Offer for Boosting Viral Vector Production	Novasep
02-Dec-2019	Ardelyx to Host Conference Call on December 3 to Review Results from the Pivotal Phase 3 PHREEDOM Study	Ardelyx
02-Dec-2019	Amgen Announces Data Being Presented At ASH 2019	Amgen
02-Dec-2019	Southwest Transplant Alliance Expands Automated Electronic Referral System to Save More Lives	Southwest Transplant Alliance
02-Dec-2019	Confo Therapeutics reports grant of two key patents for ConfoBodies™	Confo Therapeutics
02-Dec-2019	ASLAN PHARMACEUTICALS REPORTS POSITIVE PRELIMINARY DATA FROM PROOF-OF-CONCEPT STUDY FOR ASLAN004 TARGETING ATOPIC DERMATITIS	ASLAN Pharmaceuticals
02-Dec-2019	Destiny Pharma to present at the Partnerships to Tackle the Global Challenge of AMR, UK-China AMR Workshop	Destiny Pharma plc
02-Dec-2019	Cambridge Innovation Capital has attracted £1 billion of investment into Cambridge companies	Cambridge Innovation Capital
02-Dec-2019	Lewis Cameron, Former Head of Global Clinical Development at Covance, Appointed as Chief Operating Officer	Ergomed plc
02-Dec-2019	ABPI appoints Dr Richard Torbett as new Chief Executive	The Association of the British Pharmaceutical Industry (ABPI)